JP1302 structure
|
Common Name | JP1302 | ||
---|---|---|---|---|
CAS Number | 80259-18-3 | Molecular Weight | 368.47 | |
Density | 1.227g/cm3 | Boiling Point | 550.9ºC at 760 mmHg | |
Molecular Formula | C24H24N4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 287ºC |
Use of JP1302JP1302 is a potent, selective, high affinity antagonist of the α2C-adrenoceptor, with a Kb of 16 nM and a Ki of 28 nM for the human α2C-receptor. JP1302 shows antidepressant and antipsychotic-like effects. JP1302 can be used for neuropsychiatric disorders and renal dysfunction research[1][2][3]. |
Name | N-[4-(4-methylpiperazin-1-yl)phenyl]acridin-9-amine |
---|---|
Synonym | More Synonyms |
Description | JP1302 is a potent, selective, high affinity antagonist of the α2C-adrenoceptor, with a Kb of 16 nM and a Ki of 28 nM for the human α2C-receptor. JP1302 shows antidepressant and antipsychotic-like effects. JP1302 can be used for neuropsychiatric disorders and renal dysfunction research[1][2][3]. |
---|---|
Related Catalog | |
Target |
human α2C-adrenoceptor:28±2 nM (Ki) human α2B-adrenoceptor:1470±130 nM (Ki) human α2A-adrenoceptor:3150±50 nM (Ki) rodent α2D-adrenoceptor:1700±200 nM (Ki) |
In Vitro | JP1302 shows about 100-fold higher affinity than for α2A or α2B[1]. |
In Vivo | JP1302 (1-10 μmol/kg) decreases immobility time in the FST to a level similar to that seen with 10-30 μmol/kg of the antidepressant Desipramine (HY-B1272A)[1]. JP1302 (5 μmol/kg, once) is capable of complete reversal of the impairment in PPI induced in Sprague-Dawley rats by the psychotomimetic NMDA receptor antagonist, phencyclidine and similar results are found in Wistar rats[1]. JP1302 (3 mg/kg, IV, once) significantly ameliorates renal dysfunction[3]. Animal Model: Male Sprague Dawley rats (8 weeks old)[3] Dosage: 3 mg/kg Administration: IV, pre-treatment: administered 5 min before the induction of ischemia, post-treatment: injected 45 min after the initiation of reperfusion Result: Significantly ameliorated renal dysfunction in the rats at 24 h after reperfusion. post-ischemic administration of JP-1302 significantly ameliorated renal dysfunction, histological damage and reduced apoptotic cells and pro-inflammatory cytokine mRNA expression. |
References |
Density | 1.227g/cm3 |
---|---|
Boiling Point | 550.9ºC at 760 mmHg |
Molecular Formula | C24H24N4 |
Molecular Weight | 368.47 |
Flash Point | 287ºC |
Exact Mass | 368.20000 |
PSA | 31.40000 |
LogP | 4.95930 |
Index of Refraction | 1.714 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
~12% JP1302 CAS#:80259-18-3 |
Literature: Wurster, Siegfried; Engstrom, Mia; Savola, Juha-Matti; Hoglund, Iisa; Sallinen, Jukka; Haapalinna, Antti; Tauber, Andrei Yurievitch; Hoffren, Anna-Marja Katariina; Salo, Harri Elias Patent: US2001/46991 A1, 2001 ; |
Precursor 2 | |
---|---|
DownStream 0 |
gnf-pf-3427 |